Sign In | Create an Account | Welcome, . My Account | Logout | Subscribe | Submit News | Contact Us | Home RSS
 
 
 

Endoscopic Cyclophotocoagulation for the treatment of glaucoma

August 29, 2008
Provided by Eye Care for the Adirondacks
Surgeons, Kjell Dahlen, M.D. and Benjamin Vilbert, M.D are pleased to announce the addition of Endoscopic Cyclophotocoagulation procedures at Cataract Center for the Adirondacks. Endoscopic laser is applied for the treatment of glaucoma. Not all patients with glaucoma meet the criteria for this surgery. If you have an interest in this procedure, please consult your ophthalmologist or optometrist for further information.

Glaucoma is a disease of the eye usually associated with an increase in ocular pressure. If more fluid, or aqueous is produced in the eye than can drain, it causes an increase in intra-ocular pressure (IOP).

Without treatment, progressive damage occurs to the optic nerve and other ocular structures, creating visual defects and even blindness.

Approaches to the treatment of glaucoma may include medicine (eye drops), various surgical procedures that open drainage sites along the cornea and laser or freezing procedures which decrease aqueous production.

Endoscopic Cyclophotocoagulation (ECP) has proven to be a highly safe and effective treatment in the management of IOP in some patients with glaucoma.

The combined procedure involves performing ECP at the time of cataract surgery. First, the opaque, crystalline lens is removed from the eye, leaving the outer capsular bag. The new lens is implanted and afterwards, the endoscope is inserted through the same incision made for the cataract surgery and ECP proceeds.

ECP is a surgical procedure that effectively inhibits the production of aqueous fluid in the eye. Fluid is produced by a ring of tiny organs under the iris, known as the ciliary processes. By directing laser energy, from inside the eye, the surface cells of the ciliary processes are treated, typically resulting in a decrease in intra-ocular pressure. This may allow for a reduction in IOP.

ECP was pioneered in the early 90s, it has been practiced and refined globally for more than a decade. The procedure is minimally invasive, has an outstanding safety record and follow-up care is uncomplicated. ECP offers the possibility of a reduction in eye pressure which may lead to the ability to reduce or discontinue glaucoma medications. Please keep in mind that responses to therapy are individualized and not all patients will experience the same results.

 
 

 

I am looking for:
in:
News, Blogs & Events Web